AEPBI
ERAS icon

AH Equity Partners Bio II’s Erasca ERAS Stock Holding History

AH Equity Partners Bio II’s Portfolio ERAS Stock Details ERAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$19.5M Hold
2,500,000
– – 13.59% 3
2022
Q2 		$13.9M Hold
2,500,000
– – 9.78% 3
2022
Q1 		$21.5M Hold
2,500,000
– – 12.39% 3
2021
Q4 		$39M Buy
+2,500,000
New +$42.8M 20.28% 2

Other funds holding ERAS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AH Equity Partners Bio II's ERAS Position: Q3 2022 in Review

AH Equity Partners Bio II held its Erasca (ERAS) position steady in Q3 2022 at 2,500,000 shares worth $19.5M. The position accounts for 13.59% of the portfolio, ranked #3.

AH Equity Partners Bio II first reported a position in ERAS in Q4 2021 and has held it in 4 quarters since. The position peaked at $39M in Q4 2021. 88 funds tracked by Wall St. Rank hold ERAS as of Q3 2022.

  • AH Equity Partners Bio II held 2,500,000 shares of Erasca worth $19.5M as of Q3 2022.
  • AH Equity Partners Bio II left its Erasca share count unchanged in Q3 2022.
  • Erasca made up 13.59% of AH Equity Partners Bio II's portfolio in Q3 2022, its #3 holding.
  • AH Equity Partners Bio II first reported a position in Erasca in Q4 2021 and has held it in 4 quarters since.
  • AH Equity Partners Bio II's Erasca position peaked at $39M in Q4 2021.
  • 88 funds tracked by Wall St. Rank held Erasca as of Q3 2022.

Based on AH Equity Partners Bio II's 13F filing for Q3 2022, filed 14 Nov 2022.